Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Adverse Drug Events Reporting News
ASTRO 2018Precision RT May Prove Curative in Oligometastatic CancerPrecision, high-dose radiotherapy targeting isolated metastatic lesions significantly boosts overall and progression-free survival, with good quality of life for patients with oliogometastatic tumors.
Medscape Medical News, October 2018
ESMO 2018Gender Differences in Chemo Side EffectsAlthough outcomes and rates overall toxicity of esophagogastric cancer chemotherapy are similar for men and women, rates of nausea, diarrhea, and hair loss are higher in women, warn UK scientists.
Oral Semaglutide a 'PIONEER' in the Treatment of T2DDr Martin Haluzik discusses the results of the PIONEER 1 trial, which evaluated the efficacy and safety of oral semaglutide, the first GLP-1 receptor agonist in tablet formulation.
Medscape Diabetes & Endocrinology, October 19, 2018
